Citation: Mc. Allen et al., INHIBITION OF LIGAND-GATED CATION-SELECTIVE CHANNELS BY NONSTEROIDAL ANTIESTROGENS, European journal of neuroscience, 10, 1998, pp. 2801-2801
Citation: Mc. Allen et al., RAPID-DETERMINATION OF ORAL PHARMACOKINETICS AND PLASMA-FREE FRACTIONUSING COCKTAIL APPROACHES - METHODS AND APPLICATION, Pharmaceutical research, 15(1), 1998, pp. 93-97
Citation: Md. Kogan et al., THE ASSOCIATION BETWEEN ADEQUACY OF PRENATAL-CARE UTILIZATION AND SUBSEQUENT PEDIATRIC CARE UTILIZATION IN THE UNITED-STATES, Pediatrics (Evanston), 102(1), 1998, pp. 25-30
Citation: Mc. Allen et al., INHIBITION OF LIGAND-GATED CATION-SELECTIVE CHANNELS BY TAMOXIFEN, European journal of pharmacology, 354(2-3), 1998, pp. 261-269
Citation: Mc. Allen et al., QUANTITATION OF INO]-3-PHENYLPROPIONYLAMINO)PROPIONYLAMINO)BUTYRIC ACID ISOPROPYL ESTER (CP-80,794), A RENIN INHIBITOR, AND ITS HYDROLYTIC CLEAVAGE METABOLITE 2-[(MORPHOLINE-4-CARBONYL)AMINO]-3-PHENYLPROPIONICACID (CP-84,364) IN DOG AND HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 696(2), 1997, pp. 243-251
Authors:
SANDERS I
ALLEN MC
MATTHEWS IM
CAMPBELL MM
Citation: I. Sanders et al., DISPLAY OF FIXED RESIDUES ON VARIABLE CYCLIC SCAFFOLDS - A NOVEL-APPROACH TO PEPTIDE COMBINATORIAL LIBRARY SYNTHESIS, Bioorganic & medicinal chemistry letters, 7(20), 1997, pp. 2603-2606
Authors:
DAY WW
ALLEN MC
HAMANAKA ES
AIELLO RJ
MAYNE JT
SHAH TS
Citation: Ww. Day et al., PRECLINICAL DRUG-METABOLISM STUDIES IN RAT, MOUSE, DOG AND MONKEY WITH ALLOMETRIC SCALING FOR CP-340,868, A NOVEL SQUALENE SYNTHETASE INHIBITOR, Atherosclerosis, 134(1-2), 1997, pp. 122-122
Citation: Mc. Allen et Gr. Alexander, USING MOTOR MILESTONES AS A MULTISTEP PROCESS TO SCREEN PRETERM INFANTS FOR CEREBRAL-PALSY, Developmental Medicine and Child Neurology, 39(1), 1997, pp. 12-16
Authors:
BELCHER HME
GITTLESOHN A
CAPUTE AJ
ALLEN MC
Citation: Hme. Belcher et al., USING THE CLINICAL LINGUISTIC AND AUDITORY MILESTONE SCALE FOR DEVELOPMENTAL SCREENING IN HIGH-RISK PRETERM INFANTS, Clinical pediatrics, 36(11), 1997, pp. 635-642
Citation: Mc. Allen et Ww. Day, DETERMINATION OF YL-IMIDAZO[4,5-B]PYRIDIN-3-YLMETHYL)THIOPHEN-2-YL] CYCLOPENT-3-ENECARBOXYLIC ACID (CP-191,166), AN ANGIOTENSIN-II ANTAGONIST, IN DOG AND RAT PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 675(2), 1996, pp. 265-271
Citation: Mc. Allen et al., HISTAMINE FORMING CAPACITY (HFC) AND ITS MODULATION BY H-3 RECEPTOR LIGANDS IN A MODEL OF BRONCHIAL HYPERRESPONSIVENESS, Inflammation research, 45(3), 1996, pp. 118-122
Citation: Pk. Donohue et al., EFFECT OF PERINATAL FACTORS ON NICU LENGTH OF STAY IN VERY-LOW-BIRTH-WEIGHT PRETERM INFANTS, Pediatric research, 39(4), 1996, pp. 1556-1556
Authors:
ROGERS BT
ZORN WA
MSALL ME
LYNCH L
BREGMAN J
BUCKWALD S
SHAH P
GOLDSTEIN RF
ALLEN MC
HUDAK ML
Citation: Bt. Rogers et al., 2-YEAR NEURODEVELOPMENTAL OUTCOME OF INFANTS LESS-THAN-1350G ENROLLEDIN A MULTICENTER COMPARISON TRIAL OF EXOSURF (EXO) AND INFASURF (INFA) FOR THE TREATMENT OF RDS, Pediatric research, 39(4), 1996, pp. 1648-1648
Authors:
ZORN WA
MSALL ME
ROGERS BT
BREGMAN J
GOLDSTEIN RF
ALLEN MC
HUDAK ML
Citation: Wa. Zorn et al., 2-YEAR NEURODEVELOPMENTAL OUTCOME OF INFANTS LESS-THAN-29 WEEKS ENROLLED IN A MULTICENTER COMPARISON TRIAL OF EXOSURF (EXO) AND INFASURF (INFA) PROPHYLAXIS FOR RDS, Pediatric research, 39(4), 1996, pp. 1696-1696
Citation: Co. Shuler et al., VALIDATION OF ORTHOSTATIC CHALLENGE METHOD IN THE EVALUATION OF CHILDREN WITH UNEXPLAINED SYNCOPE, Pediatric research, 37(4), 1995, pp. 35-35
Citation: Mc. Allen et E. Atkins, DEVELOPMENTAL DISABILITY IN PRETERM INFANTS WITH INTRAPARENCHYMAL HEMORRHAGE, Pediatric research, 37(4), 1995, pp. 248-248
Citation: M. Nigam et al., AGREEMENT OF POSTNATAL GESTATIONAL-AGE MEASURES WITH VALIDATED PRENATAL ESTIMATE IN PRETERM NEONATES, Pediatric research, 37(4), 1995, pp. 266-266
Citation: Mc. Allen et al., HISTAMINE FORMING CAPACITY AND ITS MODULATION BY THE H3 RECEPTOR IN AMODEL OF ACUTE BRONCHIAL HYPERRESPONSIVENESS, British Journal of Pharmacology, 114, 1995, pp. 55-55